TECHNICAL FIELD
The present invention relates to pharmaceutical products for the treatment of sepsis and, in particular to products including an antibody to TNF-.alpha. (tumour necrosis factor alpha). As used herein the term sepsis encompasses Gram negative and Gram positive bacteremia, septicemia